MedPath

IRINOTECAN HYDROCHLORIDE INJECTION

IRINOTECAN HYDROCHLORIDE INJECTION

Approved
DIN Number

02501295

Drug Class

Human

Market Date

May 19, 2022

Company
HC

auro pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02501295
AIG Number0132910001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01CE02 IRINOTECAN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

IRINOTECAN HYDROCHLORIDEActive
Strength: 500 MG / 25 ML
Monograph: IRINOTECAN HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.